Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
897.60B | 904.88B | 790.93B | 619.43B | 610.23B | Gross Profit |
266.11B | 259.43B | 235.06B | 196.22B | 174.15B | EBIT |
136.10B | 139.61B | 140.29B | 123.05B | 105.73B | EBITDA |
193.83B | 189.38B | 165.30B | 168.41B | 122.28B | Net Income Common Stockholders |
110.45B | 113.50B | 122.19B | 107.95B | 97.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
407.79B | 401.87B | 351.28B | 346.12B | 335.19B | Total Assets |
1.15T | 1.18T | 1.08T | 831.43B | 817.06B | Total Debt |
164.65B | 174.67B | 175.93B | 104.51B | 97.24B | Net Debt |
67.70B | 82.79B | 72.09B | -65.28B | -47.26B | Total Liabilities |
401.24B | 394.07B | 420.51B | 276.84B | 257.73B | Stockholders Equity |
749.88B | 781.16B | 658.16B | 553.10B | 557.46B |
Cash Flow | Free Cash Flow | |||
165.71B | 115.77B | 90.64B | 127.97B | 77.15B | Operating Cash Flow |
176.22B | 130.60B | 110.80B | 147.55B | 100.64B | Investing Cash Flow |
11.68B | -84.06B | -224.50B | 7.74B | 34.01B | Financing Cash Flow |
-182.57B | -60.88B | 46.59B | -128.84B | -151.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $74.25B | 23.44 | 29.00% | 2.32% | 3.85% | -0.38% | |
78 Outperform | $8.69B | 17.46 | 22.15% | 1.26% | 6.46% | -16.94% | |
77 Outperform | $191.14B | 25.19 | 27.26% | 1.88% | 4.10% | 9.78% | |
76 Outperform | $38.30B | 16.36 | 16.61% | 1.56% | 4.09% | 14.05% | |
73 Outperform | $9.08B | 20.45 | 12.80% | ― | 0.80% | 10.05% | |
67 Neutral | $30.00B | 19.52 | 16.91% | 2.12% | -2.83% | 106.18% | |
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% |